Cowen & Co. Initiates Coverage On AXOVANT SCIENCES LTD ORD to Outperform

Cowen & Co. Initiates Coverage On AXOVANT SCIENCES LTD ORD(AXON). The shares have been rated Outperform. The rating by Cowen & Co. was issued on Feb 3, 2017.

AXOVANT SCIENCES LTD ORD (AXON) shares turned negative on Tuesdays trading session with the shares closing down -0.06 points or -0.46% at a volume of 2,87,395. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $13.24. The peak price level was also seen at $13.24 while the days lowest was $12.83. Finally the shares closed at $12.91. The 52-week high of the shares is $17.66 while the 52-week low is $8.86. According to the latest information available, the market cap of the company is $1,280 M.

AXOVANT SCIENCES LTD ORD(AXON) last announced its earnings results on Nov 7, 2016 for Fiscal Year 2017 and Q2.Earnings per share were $-0.43. The reported EPS was above estimates by $0.06 or NaN%. Analysts had estimated an EPS of $-0.37.

Several Insider Transactions has been reported to the SEC. On Mar 14, 2016, Mark Altmeyer (Pres&Chief Commercial Officer) purchased 2,300 shares at $11.14 per share price.

Share this post

Leave a Reply